|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7169401||HILL DERMACEUTICALS||Topical skin care composition containing refined peanut oil|| |
(2 months ago)
Tolak is owned by Hill Dermaceuticals.
Tolak contains Fluorouracil.
Tolak has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Tolak are:
Tolak was authorised for market use on 18 September, 2015.
Tolak is available in cream;topical dosage forms.
The generics of Tolak are possible to be released after 18 July, 2023.
Market Authorisation Date: 18 September, 2015
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic